Organism name | Melia azadirach |
---|---|
Genus | Melia |
Family | Meliaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Melia azedarach |
---|---|
Linked NCBI taxonomy ID | 155640 |
Linked level | species |
Family in NCBI taxonomy | Meliaceae |
---|---|
ID | 43707 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | rosids |
---|---|
ID | 71275 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00046069
![]() |
Kulinone
|
CHEMBL464491
|
No. 119 | No. 51 |
![]() |
|||
C00020065
![]() |
alpha-Cadinol
/ (-)-alpha-Cadinol |
CHEMBL486795
|
No. 205 | No. 38 |
![]() |
|||
C00020150
![]() |
(-)-Torreyol
/ delta-Cadinol |
CHEMBL486795
|
No. 205 | No. 38 |
![]() |
|||
C00035686
![]() |
Melianone
|
CHEMBL486466
|
No. 264 | No. 51 |
![]() |
|||
C00000816
![]() |
beta-Pinene
|
CHEMBL501351
|
C010789
|
No. 476 | No. 35 |
![]() |
||
C00000805
![]() |
alpha-Pinene
|
CHEMBL442565
|
C005451
|
3 / 3 / 2 | 0 / 1 | No. 476 | No. 35 |
![]() |
C00043791
![]() |
Ohchinolal
|
CHEMBL501420
|
No. 591 | No. 51 |
![]() |
|||
C00000823
![]() |
Limonene
|
CHEMBL15799
CHEMBL449062 |
C008281
|
7 / 21 / 48 | 6 / 6 | No. 848 | No. 35 |
![]() |
C00003047
![]() |
Linalool
/ (R)-linalool / (R)-(-)-3,7-Dimethyl-1,6-octadien-3-ol |
CHEMBL25306
CHEMBL235672 |
C018584
|
6 / 8 / 2 | 35 / 4 | No. 958 | No. 34 |
![]() |
C00048262
![]() |
1-p-Menthene
|
No. 1052 | No. 35 |
![]() |
||||
C00007636
![]() |
delta-Cadinene
|
CHEMBL445759
|
No. 1524 | No. 39 |
![]() |
|||
C00002645
![]() |
p-Cresol
/ 4-Methylphenol |
CHEMBL16645
|
C032538
|
8 / 4 / 4 | 10 / 4 | No. 1546 |
![]() |
|
C00030878
![]() |
o-Cresol
|
CHEMBL46931
|
C034047
|
4 / 9 / 3 | 1 / 4 | No. 1546 |
![]() |
|
C00035128
![]() |
m-Cresol
/ m-Oxytoluene |
CHEMBL298312
|
C042041
|
6 / 4 / 1 | 1 / 3 | No. 1546 |
![]() |
|
C00000844
![]() |
Citronellol
|
CHEMBL395827
CHEMBL1907993 CHEMBL1907995 |
C007078
|
7 / 5 / 4 | 1 / 1 | No. 1948 | No. 34 |
![]() |
C00003040
![]() |
p-Cymene
|
CHEMBL442915
|
C007210
|
No. 2172 | No. 35 |
![]() |
||
C00002654
![]() |
Guaiacol
/ o-Guaiacol |
CHEMBL13766
|
D006139
|
15 / 18 / 47 | 3 / 1 | No. 2352 |
![]() |
|
C00003029
![]() |
Camphene
|
CHEMBL506889
CHEMBL510535 |
C019286
|
No. 2460 | No. 35 |
![]() |
||
C00033189
![]() |
Melianin B
|
CHEMBL446959
|
No. 2887 |
![]() |
||||
C00000861
![]() |
Terpinolene
|
CHEMBL454697
|
C027009
|
1 / 0 | No. 3725 |
![]() |
||
C00002664
![]() |
Phenol
|
CHEMBL14060
|
D019800
|
111 / 52 / 47 | 101 / 30 | No. 6006 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00000823 C00000844 C00002645 C00002654 C00002664 C00030878 C00035128 | 0 / 0 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00000823 C00003047 C00035128 | 3 / 1 |
P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | C00000805 C00002645 C00002654 | 0 / 0 |
P10275 | Androgen receptor | NR3C4 | C00002645 C00002654 C00002664 | 3 / 4 |
P19793 | Retinoic acid receptor RXR-alpha | NR2B1 | C00000823 C00002664 C00035128 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000823 C00000844 C00002664 | 0 / 3 |
P22303 | Acetylcholinesterase | Hydrolase | C00002645 C00002664 C00035128 | 1 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00000823 C00002654 | 7 / 37 |
Q9Y4X1 | UDP-glucuronosyltransferase 2A1 | Enzyme | C00000844 C00003047 | 0 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00000844 C00003047 | 0 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00000805 C00002664 | 0 / 0 |
P03956 | Interstitial collagenase | M10A | C00002654 C00002664 | 0 / 1 |
P00915 | Carbonic anhydrase 1 | Lyase | C00002654 C00002664 | 0 / 0 |
O60656 | UDP-glucuronosyltransferase 1-9 | Enzyme | C00000844 C00002645 | 0 / 0 |
P00918 | Carbonic anhydrase 2 | Lyase | C00002654 C00002664 | 1 / 2 |
P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00000844 C00003047 | 5 / 1 |
P19224 | UDP-glucuronosyltransferase 1-6 | Enzyme | C00002645 C00002664 | 0 / 0 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00000805 C00002654 | 3 / 2 |
P14780 | Matrix metalloproteinase-9 | M10A | C00002654 C00002664 | 2 / 2 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00002664 | 0 / 0 |
Q8N1Q1 | Carbonic anhydrase 13 | Lyase | C00002664 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00000823 | 11 / 10 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00002664 | 0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00002664 | 0 / 0 |
P29466 | Caspase-1 | C14 | C00002664 | 0 / 0 |
P22894 | Neutrophil collagenase | M10A | C00002654 | 0 / 0 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00002664 | 0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00002664 | 1 / 1 |
P25021 | Histamine H2 receptor | Histamine receptor | C00002664 | 0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00002664 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00002664 | 1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00002664 | 0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00002664 | 0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00002664 | 0 / 0 |
P04066 | Tissue alpha-L-fucosidase | Enzyme | C00002664 | 1 / 2 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00002664 | 0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00002664 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00002664 | 0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00002664 | 0 / 1 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00002664 | 1 / 8 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00002664 | 2 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00002664 | 0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00002664 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00002664 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00002664 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00002664 | 0 / 0 |
P23280 | Carbonic anhydrase 6 | Lyase | C00002664 | 0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00002664 | 0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00002664 | 1 / 1 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00002664 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00002664 | 1 / 0 |
Q9ULX7 | Carbonic anhydrase 14 | Lyase | C00002664 | 0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00000844 | 0 / 0 |
O43570 | Carbonic anhydrase 12 | Lyase | C00002664 | 1 / 2 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00002664 | 0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00035128 | 0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00030878 | 2 / 0 |
P50225 | Sulfotransferase 1A1 | Enzyme | C00002645 | 0 / 0 |
P43166 | Carbonic anhydrase 7 | Lyase | C00002664 | 0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00002664 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00002664 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00002664 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00002664 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00002664 | 1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00002664 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00002664 | 0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00002664 | 0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00002664 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00002664 | 0 / 0 |
P10145 | Interleukin-8 | Secreted protein | C00002645 | 0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00002664 | 1 / 0 |
P35218 | Carbonic anhydrase 5A, mitochondrial | Lyase | C00002664 | 0 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00002664 | 0 / 0 |
P08311 | Cathepsin G | S1A | C00002664 | 0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00002664 | 1 / 0 |
Q9Y2D0 | Carbonic anhydrase 5B, mitochondrial | Lyase | C00002664 | 0 / 0 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00002664 | 0 / 0 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00030878 | 7 / 3 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00003047 | 0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | C00002664 | 0 / 1 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00002664 | 2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00002664 | 0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00002664 | 0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00002664 | 2 / 0 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00002664 | 5 / 3 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00002664 | 5 / 9 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00002664 | 1 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | C00002664 | 0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00002664 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00002664 | 3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00002664 | 0 / 0 |
P06280 | Alpha-galactosidase A | Enzyme | C00002664 | 1 / 1 |
Q96RI1 | Bile acid receptor | NR1H4 | C00030878 | 0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00002664 | 1 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00002664 | 0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00002664 | 2 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00002664 | 0 / 0 |
Q16790 | Carbonic anhydrase 9 | Lyase | C00002664 | 0 / 1 |
P08253 | 72 kDa type IV collagenase | M10A | C00002654 | 1 / 3 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00002664 | 0 / 0 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00002654 | 0 / 0 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00002664 | 0 / 0 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00000823 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00002664 | 1 / 1 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00002664 | 1 / 0 |
P08246 | Neutrophil elastase | S1A | C00002664 | 2 / 1 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00002664 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00002664 | 0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00002664 | 0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00002664 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00002664 | 0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00002664 | 0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00002664 | 0 / 0 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00002664 | 2 / 2 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00002664 | 1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00002664 | 0 / 1 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00002664 | 0 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00002664 | 0 / 0 |
P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00002654 | 0 / 0 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00002664 | 1 / 0 |
P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00003047 | 3 / 0 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00002664 | 1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00002664 | 0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00002664 | 0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00002664 | 0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00002664 | 1 / 1 |
P07451 | Carbonic anhydrase 3 | Lyase | C00002664 | 0 / 0 |
P06239 | Tyrosine-protein kinase Lck | Src | C00002664 | 0 / 1 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00002664 | 0 / 0 |
P08254 | Stromelysin-1 | M10A | C00002654 | 1 / 0 |
P22748 | Carbonic anhydrase 4 | Lyase | C00002664 | 1 / 1 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00035128 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00002654 | 0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00002664 | 1 / 1 |
P18507 | Gamma-aminobutyric acid receptor subunit gamma-2 | GABA-A gamma | C00002664 | 4 / 2 |
P47870 | Gamma-aminobutyric acid receptor subunit beta-2 | GABA-A beta | C00002664 | 0 / 0 |
P14867 | Gamma-aminobutyric acid receptor subunit alpha-1 | GABA-A alpha | C00002664 | 1 / 1 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
213 | ALB, PRO0883, PRO0903, PRO1341 | albumin |
C00002645
C00002654
C00002664
C00030878
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00000823
C00002664
C00003047
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00000823
C00003047
|
3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00000823
C00002664
|
1571 | CYP2E1, CPE1, CYP2E, P450-J, P450C2E | cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) |
C00002645
C00002664
|
4852 | NPY, PYY4 | neuropeptide Y |
C00000823
C00003047
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00002645
C00002664
|
1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00002645
C00002664
|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00000861
C00003047
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00002645
C00002664
|
4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00002664
C00003047
|
4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog |
C00002664
C00003047
|
5292 | PIM1, PIM | pim-1 oncogene (EC:2.7.11.1) |
C00002664
|
1027 | CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1 | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
C00003047
|
1028 | CDKN1C, BWCR, BWS, KIP2, WBS, p57, p57Kip2 | cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
C00003047
|
1030 | CDKN2B, CDK4I, INK4B, MTS2, P15, TP15, p15INK4b | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
C00003047
|
1447 | CSN2, CASB | casein beta |
C00003047
|
1509 | CTSD, CLN10, CPSD | cathepsin D (EC:3.4.23.5) |
C00003047
|
1906 | EDN1, ET1, HDLCQ7, PPET1 | endothelin 1 |
C00003047
|
1956 | EGFR, ERBB, ERBB1, HER1, PIG61, mENA | epidermal growth factor receptor (EC:2.7.10.1) |
C00003047
|
2335 | FN1, CIG, ED-B, FINC, FN, FNZ, GFND, GFND2, LETS, MSF | fibronectin 1 |
C00003047
|
1647 | GADD45A, DDIT1, GADD45 | growth arrest and DNA-damage-inducible, alpha |
C00003047
|
2729 | GCLC, GCL, GCS, GLCL, GLCLC | glutamate-cysteine ligase, catalytic subunit (EC:6.3.2.2) |
C00003047
|
3156 | HMGCR, LDLCQ3 | 3-hydroxy-3-methylglutaryl-CoA reductase (EC:1.1.1.34) |
C00003047
|
3297 | HSF1, HSTF1 | heat shock transcription factor 1 |
C00003047
|
3320 | HSP90AA1, EL52, HSP86, HSP89A, HSP90A, HSP90N, HSPC1, HSPCA, HSPCAL1, HSPCAL4, HSPN, Hsp89, Hsp90, LAP2 | heat shock protein 90kDa alpha (cytosolic), class A member 1 |
C00003047
|
3308 | HSPA4, APG-2, HS24/P52, HSPH2, RY, hsp70, hsp70RY | heat shock 70kDa protein 4 |
C00003047
|
3316 | HSPB2, HSP27, Hs.78846, LOH11CR1K, MKBP | heat shock 27kDa protein 2 |
C00003047
|
3398 | ID2, GIG8, ID2A, ID2H, bHLHb26 | inhibitor of DNA binding 2, dominant negative helix-loop-helix protein |
C00003047
|
3638 | INSIG1, CL-6, CL6 | insulin induced gene 1 |
C00003047
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00003047
|
8850 | KAT2B, CAF, P, P/CAF, PCAF | K(lysine) acetyltransferase 2B (EC:2.3.1.48) |
C00003047
|
4193 | MDM2, ACTFS, HDMX, hdm2 | MDM2 oncogene, E3 ubiquitin protein ligase |
C00003047
|
330 | BIRC3, AIP1, API2, CIAP2, HAIP1, HIAP1, MALT2, MIHC, RNF49, c-IAP2 | baculoviral IAP repeat containing 3 |
C00003047
|
329 | BIRC2, API1, HIAP2, Hiap-2, MIHB, RNF48, c-IAP1, cIAP1 | baculoviral IAP repeat containing 2 |
C00003047
|
100124292 |
C00003047
|
||
7295 | TXN, TRDX, TRX, TRX1 | thioredoxin |
C00003047
|
7471 | WNT1, BMND16, INT1, OI15 | wingless-type MMTV integration site family, member 1 |
C00003047
|
26118 | WSB1, SWIP1, WSB-1 | WD repeat and SOCS box containing 1 |
C00003047
|
1386 | ATF2, CRE-BP1, CREB2, HB16, TREB7 | activating transcription factor 2 (EC:2.3.1.48) |
C00003047
|
6376 | CX3CL1, ABCD-3, C3Xkine, CXC3, CXC3C, NTN, NTT, SCYD1, fractalkine, neurotactin | chemokine (C-X3-C motif) ligand 1 |
C00002645
|
1646 | AKR1C2, AKR1C-pseudo, BABP, DD, DD2, DDH2, HAKRD, HBAB, MCDR2, SRXY8 | aldo-keto reductase family 1, member C2 (EC:1.3.1.20 1.1.1.357) |
C00003047
|
1565 | CYP2D6, CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, P450-DB1, P450C2D, P450DB1 | cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) |
C00002645
|
3265 | HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1 | Harvey rat sarcoma viral oncogene homolog |
C00000823
|
50848 | F11R, CD321, JAM, JAM1, JAMA, JCAM, KAT, PAM-1 | F11 receptor |
C00002645
|
3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00002645
|
7442 | TRPV1, VR1 | transient receptor potential cation channel, subfamily V, member 1 |
C00000844
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00000823
|
7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 |
C00002645
|
6329 | SCN4A, HOKPP2, HYKPP, HYPP, NAC1A, Na(V)1.4, Nav1.4, SkM1 | sodium channel, voltage-gated, type IV, alpha subunit |
C00035128
|
759 | CA1, CA-I, CAB, Car1 | carbonic anhydrase I (EC:4.2.1.1) |
C00002654
|
760 | CA2, CA-II, CAC, CAII, Car2 | carbonic anhydrase II (EC:4.2.1.1) |
C00002654
|
10965 | ACOT2, CTE-IA, CTE1A, MTE1, PTE2, PTE2A, ZAP128 | acyl-CoA thioesterase 2 (EC:3.1.2.2) |
C00002664
|
174 | AFP, FETA, HPAFP | alpha-fetoprotein |
C00002664
|
249 | ALPL, AP-TNAP, APTNAP, HOPS, TNAP, TNSALP | alkaline phosphatase, liver/bone/kidney (EC:3.1.3.1) |
C00002664
|
25805 | BAMBI, NMA | BMP and activin membrane-bound inhibitor |
C00002664
|
8553 | BHLHE40, BHLHB2, DEC1, HLHB2, SHARP-2, STRA13, Stra14 | basic helix-loop-helix family, member e40 |
C00002664
|
10904 | BLCAP, BC10 | bladder cancer associated protein |
C00002664
|
813 | CALU | calumenin |
C00002664
|
6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00002664
|
890 | CCNA2, CCN1, CCNA | cyclin A2 |
C00002664
|
9469 | CHST3, C6ST, C6ST1, HSD | carbohydrate (chondroitin 6) sulfotransferase 3 (EC:2.8.2.17) |
C00002664
|
9076 | CLDN1, CLD1, ILVASC, SEMP1 | claudin 1 |
C00002664
|
1277 | COL1A1, OI4 | collagen, type I, alpha 1 |
C00002664
|
1385 | CREB1, CREB | cAMP responsive element binding protein 1 |
C00002664
|
100160140 |
C00002664
|
||
4051 | CYP4F3, CPF3, CYP4F, LTB4H | cytochrome P450, family 4, subfamily F, polypeptide 3 (EC:1.14.13.30) |
C00002664
|
26528 | DAZAP1 | DAZ associated protein 1 |
C00002664
|
55802 | DCP1A, HSA275986, Nbla00360, SMAD4IP1, SMIF | decapping mRNA 1A |
C00002664
|
1654 | DDX3X, DBX, DDX14, DDX3, HLP2 | DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked (EC:3.6.4.13) |
C00002664
|
1843 | DUSP1, CL100, HVH1, MKP-1, MKP1, PTPN10 | dual specificity phosphatase 1 (EC:3.1.3.16 3.1.3.48) |
C00002664
|
22936 | ELL2 | elongation factor, RNA polymerase II, 2 |
C00002664
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00002664
|
2114 | ETS2, ETS2IT1 | v-ets avian erythroblastosis virus E26 oncogene homolog 2 |
C00002664
|
355 | FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6 | Fas cell surface death receptor |
C00002664
|
26190 | FBXW2, FBW2, Fwd2, Md6 | F-box and WD repeat domain containing 2 |
C00002664
|
8061 | FOSL1, FRA, FRA1, fra-1 | FOS-like antigen 1 |
C00002664
|
2623 | GATA1, ERYF1, GATA-1, GF-1, GF1, NF-E1, NFE1, XLANP, XLTDA, XLTT | GATA binding protein 1 (globin transcription factor 1) |
C00002664
|
2624 | GATA2, DCML, MONOMAC, NFE1B | GATA binding protein 2 |
C00002664
|
9329 | GTF3C4, KAT12, TFIII90, TFIIIC290, TFIIIC90, TFIIICDELTA | general transcription factor IIIC, polypeptide 4, 90kDa (EC:2.3.1.48) |
C00002664
|
3014 | H2AFX, H2A.X, H2A/X, H2AX | H2A histone family, member X |
C00002664
|
26762 | HAVCR1, HAVCR, HAVCR-1, KIM-1, KIM1, TIM, TIM-1, TIM1, TIMD-1, TIMD1 | hepatitis A virus cellular receptor 1 |
C00002664
|
3043 | HBB, CD113t-C, beta-globin | hemoglobin, beta |
C00002664
|
3280 | HES1, HES-1, HHL, HRY, bHLHb39 | hes family bHLH transcription factor 1 |
C00002664
|
3145 | HMBS, PBG-D, PBGD, PORC, UPS | hydroxymethylbilane synthase (EC:2.5.1.61) |
C00002664
|
3188 | HNRNPH2, FTP3, HNRPH', HNRPH2, hnRNPH' | heterogeneous nuclear ribonucleoprotein H2 (H') |
C00002664
|
3399 | ID3, HEIR-1, bHLHb25 | inhibitor of DNA binding 3, dominant negative helix-loop-helix protein |
C00002664
|
3552 | IL1A, IL-1A, IL1, IL1-ALPHA, IL1F1 | interleukin 1, alpha |
C00002664
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00002664
|
54556 | ING3, Eaf4, ING2, MEAF4, p47ING3 | inhibitor of growth family, member 3 |
C00002664
|
7071 | KLF10, EGR-alpha, EGRA, TIEG, TIEG1 | Kruppel-like factor 10 |
C00002664
|
1316 | KLF6, BCD1, CBA1, COPEB, CPBP, GBF, PAC1, ST12, ZF9 | Kruppel-like factor 6 |
C00002664
|
3840 | KPNA4, IPOA3, QIP1, SRP3 | karyopherin alpha 4 (importin alpha 3) |
C00002664
|
4041 | LRP5, BMND1, EVR1, EVR4, HBM, LR3, LRP7, OPPG, OPS, OPTA1, VBCH2 | low density lipoprotein receptor-related protein 5 |
C00002664
|
10905 | MAN1A2, MAN1B | mannosidase, alpha, class 1A, member 2 (EC:3.2.1.113) |
C00002664
|
4170 | MCL1, BCL2L3, EAT, MCL1-ES, MCL1L, MCL1S, Mcl-1, TM, bcl2-L-3, mcl1/EAT | myeloid cell leukemia sequence 1 (BCL2-related) |
C00002664
|
4247 | MGAT2, CDG2A, CDGS2, GLCNACTII, GNT-II, GNT2 | mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase (EC:2.4.1.143) |
C00002664
|
4353 | MPO | myeloperoxidase (EC:1.11.2.2) |
C00002664
|
740 | MRPL49, C11orf4, L49mt, MRP-L49, NOF, NOF1 | mitochondrial ribosomal protein L49 |
C00002664
|
4496 | MT1H, MT-0, MT-1H, MT-IH, MT1 | metallothionein 1H |
C00002664
|
4501 | MT1X, MT-1l, MT1 | metallothionein 1X |
C00002664
|
4778 | NFE2, NF-E2, p45 | nuclear factor, erythroid 2 |
C00002664
|
4800 | NFYA, CBF-A, CBF-B, HAP2, NF-YA | nuclear transcription factor Y, alpha |
C00002664
|
1728 | NQO1, DHQU, DIA4, DTD, NMOR1, NMORI, QR1 | NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) |
C00002664
|
8431 | NR0B2, SHP, SHP1 | nuclear receptor subfamily 0, group B, member 2 |
C00002664
|
57162 | PELI1 | pellino E3 ubiquitin protein ligase 1 |
C00002664
|
8864 | PER2, FASPS, FASPS1 | period circadian clock 2 |
C00002664
|
5293 | PIK3CD, P110DELTA, PI3K, p110D | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta (EC:2.7.1.153) |
C00002664
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00003047
|
9240 | PNMA1, MA1 | paraneoplastic Ma antigen 1 |
C00002664
|
5411 | PNN, DRS, DRSP, SDK3, memA | pinin, desmosome associated protein |
C00002664
|
10908 | PNPLA6, NTE, NTEMND, SPG39, iPLA2delta, sws | patatin-like phospholipase domain containing 6 (EC:3.1.1.5) |
C00002664
|
5468 | PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma | peroxisome proliferator-activated receptor gamma |
C00002664
|
8493 | PPM1D, PP2C-DELTA, WIP1 | protein phosphatase, Mg2+/Mn2+ dependent, 1D (EC:3.1.3.16) |
C00002664
|
5591 | PRKDC, DNA-PKcs, DNAPK, DNPK1, HYRC, HYRC1, XRCC7, p350 | protein kinase, DNA-activated, catalytic polypeptide (EC:2.7.11.1) |
C00002664
|
38175 |
C00002664
|
||
9367 | RAB9A, RAB9 | RAB9A, member RAS oncogene family |
C00002664
|
29803 | REPIN1, AP4, RIP60, ZNF464, Zfp464 | replication initiator 1 |
C00002664
|
10670 | RRAGA, FIP-1, FIP1, RAGA | Ras-related GTP binding A |
C00002664
|
51282 | SCAND1, RAZ1, SDP1 | SCAN domain containing 1 |
C00002664
|
22928 | SEPHS2, SPS2, SPS2b | selenophosphate synthetase 2 (EC:2.7.9.3) |
C00002664
|
150094 | SIK1, MSK, SIK, SNF1LK | salt-inducible kinase 1 (EC:2.7.11.1) |
C00002664
|
23411 | SIRT1, SIR2L1 | sirtuin 1 |
C00002664
|
9990 | SLC12A6, ACCPN, KCC3, KCC3A, KCC3B | solute carrier family 12 (potassium/chloride transporter), member 6 |
C00002664
|
6426 | SRSF1, ASF, SF2, SF2p33, SFRS1, SRp30a | serine/arginine-rich splicing factor 1 |
C00002664
|
6430 | SRSF5, HRS, SFRS5, SRP40 | serine/arginine-rich splicing factor 5 |
C00002664
|
51188 | SS18L2, KIAA-iso | synovial sarcoma translocation gene on chromosome 18-like 2 |
C00002664
|
6879 | TAF7, TAF2F, TAFII55 | TAF7 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 55kDa |
C00002664
|
23435 | TARDBP, ALS10, TDP-43 | TAR DNA binding protein |
C00002664
|
10732 | TCFL5, CHA, E2BP-1, Figlb, bHLHe82 | transcription factor-like 5 (basic helix-loop-helix) |
C00002664
|
7014 | TERF2, TRBF2, TRF2 | telomeric repeat binding factor 2 |
C00002664
|
7037 | TFRC, CD71, T9, TFR, TFR1, TR, TRFR, p90 | transferrin receptor |
C00002664
|
7050 | TGIF1, HPE4, TGIF | TGFB-induced factor homeobox 1 |
C00002664
|
10440 | TIMM17A, TIM17, TIM17A | translocase of inner mitochondrial membrane 17 homolog A (yeast) |
C00002664
|
7082 | TJP1, ZO-1 | tight junction protein 1 |
C00002664
|
7128 | TNFAIP3, A20, OTUD7C, TNFA1P2 | tumor necrosis factor, alpha-induced protein 3 (EC:3.4.19.12) |
C00002664
|
27242 | TNFRSF21, BM-018, CD358, DR6 | tumor necrosis factor receptor superfamily, member 21 |
C00002664
|
10140 | TOB1, APRO6, PIG49, TOB, TROB, TROB1 | transducer of ERBB2, 1 |
C00002664
|
10221 | TRIB1, C8FW, GIG-2, GIG2, SKIP1, TRB-1, TRB1 | tribbles pseudokinase 1 |
C00002664
|
7286 | TUFT1 | tuftelin 1 |
C00002664
|
7296 | TXNRD1, GRIM-12, TR, TR1, TRXR1, TXNR | thioredoxin reductase 1 (EC:1.8.1.9) |
C00002664
|
7357 | UGCG, GCS, GLCT1 | UDP-glucose ceramide glucosyltransferase (EC:2.4.1.80) |
C00002664
|
8876 | VNN1, HDLCQ8, Tiff66 | vanin 1 (EC:3.5.1.92) |
C00002664
|
7444 | VRK2 | vaccinia related kinase 2 (EC:2.7.11.1) |
C00002664
|
OMIM | preferred title | UniProt |
---|---|---|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
%606641 | Body mass index; bmi |
P37231
|
#300615 | Brunner syndrome |
P21397
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#114500 | Colorectal cancer; crc |
P84022
|
#614466 | Coronary heart disease, susceptibility to, 6; chds6 |
P08254
|
#218800 | Crigler-najjar syndrome, type i |
P22309
P22310 |
#606785 | Crigler-najjar syndrome, type ii |
P22309
P22310 |
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#607208 | Dravet syndrome |
P18507
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#607681 | Epilepsy, childhood absence, susceptibility to, 2; eca2 |
P18507
|
#611136 | Epilepsy, juvenile myoclonic, susceptibility to, 5; ejm5 |
P14867
|
#133239 | Esophageal cancer |
P04637
|
#615363 | Estrogen resistance; estrr |
P03372
|
#301500 | Fabry disease |
P06280
|
#230000 | Fucosidosis |
P04066
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#604233 | Generalized epilepsy with febrile seizures plus, type 1; gefsp1 |
P18507
|
#611277 | Generalized epilepsy with febrile seizures plus, type 3; gefsp3 |
P18507
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#143500 | Gilbert syndrome |
P22309
P22310 |
#137800 | Glioma susceptibility 1; glm1 |
P04626
P37231 |
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 P04637 |
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#259600 | Multicentric osteolysis, nodulosis, and arthropathy; mona |
P08253
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#159900 | Myoclonic dystonia |
P14416
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#601665 | Obesity |
P32245
P37231 |
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#600852 | Retinitis pigmentosa 17; rp17 |
P22748
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#610379 | West nile virus, susceptibility to |
P51681
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
P04637 (marker) Q16790 (marker) |
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) P08253 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
H00141 | Fucosidosis |
P04066
(related)
|
H00422 | Glycoproteinoses |
P04066
(related)
|
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) |
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P35354 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P08253 (related) P14780 (related) P35354 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
P37231 (related) |
H00033 | Adrenal carcinoma |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00125 | Fabry disease |
P06280
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00472 | Torg-Winchester syndrome |
P08253
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00808 | Idiopathic generalized epilepsies (IGEs) |
P14867
(related)
P18507 (related) |
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00783 | Febrile seizures |
P18507
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00208 | Hyperbilirubinemia |
P22309
(related)
|
H00527 | Retinitis pigmentosa (RP) |
P22748
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
|
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q9NUW8
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D003877 | Dermatitis, Contact |
C00000805
C00000823 C00002664 |
D007674 | Kidney Diseases |
C00000823
C00002645 |
D010146 | Pain |
C00002654
C00002664 |
D014202 | Tremor |
C00030878
C00002664 |
D017449 | Dermatitis, Allergic Contact |
C00030878
C00002664 |
D001859 | Bone Neoplasms |
C00002664
|
D013276 | Stomach Ulcer |
C00000823
|
D017453 | Dermatitis, Irritant |
C00003047
|
D006937 | Hypercholesterolemia |
C00003047
|
D007938 | Leukemia |
C00003047
|
D009369 | Neoplasms |
C00003047
|
D002318 | Cardiovascular Diseases |
C00002645
|
D003873 | Dermatitis, Exfoliative |
C00002645
|
D006965 | Hyperplasia |
C00002645
|
D001836 | Body Weight Changes |
C00030878
|
D008114 | Liver Neoplasms, Experimental |
C00000823
|
D008107 | Liver Diseases |
C00000823
|
D015431 | Weight Loss |
C00030878
|
D002057 | Burns, Chemical |
C00035128
|
D056486 | Drug-Induced Liver Injury |
C00035128
|
D006967 | Hypersensitivity |
C00035128
|
D012640 | Seizures |
C00000844
|
D058186 | Acute Kidney Injury |
C00002664
|
D001855 | Bone Marrow Diseases |
C00002664
|
D008569 | Memory Disorders |
C00000823
|
D001913 | Bowen's Disease |
C00002664
|
D003128 | COMA |
C00002664
|
D003556 | Cystitis |
C00002664
|
D004382 | Duodenitis |
C00002664
|
D004487 | Edema |
C00002664
|
D005756 | Gastritis |
C00002664
|
D006417 | Hematuria |
C00002664
|
D006470 | Hemorrhage |
C00002664
|
D006973 | Hypertension |
C00002664
|
D007035 | Hypothermia |
C00002664
|
D055623 | Keratosis, Actinic |
C00002664
|
D048629 | Micronuclei, Chromosome-Defective |
C00002664
|
D009784 | Occupational Diseases |
C00002664
|
D020734 | Parkinsonian Disorders |
C00002664
|
D010392 | Pemphigus |
C00002664
|
D010523 | Peripheral Nervous System Diseases |
C00002664
|
D010864 | Pilonidal Sinus |
C00002664
|
D011041 | Poisoning |
C00002664
|
D012131 | Respiratory Insufficiency |
C00002664
|
D013088 | Spermatocele |
C00002664
|
D006848 | Testicular Hydrocele |
C00002664
|
D014277 | Trigeminal Neuralgia |
C00002664
|
D014860 | Warts |
C00002664
|